Aligos Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.07

-0.44 (-9.76%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +52.1% upside

Low Target $4.22

Average Target $6.19

High Target $8.57

Current Price $4.07

Current
$4.07

Target
$6.19

$4.22 $6.19 avg $8.57

Scenario Analysis

Bear Case

$4.22

3.7%

Low target

Base Case

$6.19

+52.1%

Avg target

Bull Case

$8.57

+110.6%

High target

Risk/Reward

30.0x

Highly favorable

Price in Context

52-Week High

$13.69

-70.3% from high

52-Week Low

$3.98

+2.3% from low

Target vs 52W High

$6.19

-54.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.5%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.2%
MRNA Moderna Inc	Hold	31	32%	$149.45	-35.4%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-91.9%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.7%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-35.3%